Catumaxomab for intraperitoneal treatment of malignant ascites in epithelial cellular adhesion molecule-positive carcinomas when further systemic anticancer treatment is unsuitable ID6580
In development
Reference number: GID-TA11774
Expected publication date:
Documents
Documents created during the development process.
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6580